Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
“NOBODY HAS ANYTHING bad to say about Ana, you can’t. She was just one of life’s beautiful people with a hugely bright future ahead of her.”
18-year-old Ana Hick died after an incident at the Twisted Pepper nightclub in Dublin on Saturday night.
Rachel Sara Murphy from the Irish Film Academy where Ana studied, spoke to The Pat Kenny Show about the teenager this morning. Murphy said:
“Ana was the most extraordinary young girl, so talented. She worked hard at everything she did.
“She was a beautiful sweet young woman.
She just got it, she got acting, she could have gone all the way.
Advertisement
Ana was taken to the nearby Mater Hospital at around 3am early on Sunday morning, but is believed to have passed away at around 5pm yesterday evening.
Reports suggest that at least two ecstasy pills may have been involved in the incident, although results are awaited of the post mortem and toxicology report in order to establish cause of death.
Murphy said Ana’s parents Elga and Tim are grateful for the support they have received but have asked for privacy.
Ana’s mother, Elga, today posted a dashcam video of herself and Ana singing along to Disney’s The Little Mermaid while driving.
Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article.
Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.
Interesting semantics…
‘…will need to be fully vaccinated in order to take part in activities from getting a haircut to watching a concert…’ and then
‘…Ardern and her liberal government..’
The virus and it’s consequences for health care delivery is indifferent to the half baked, illiterate and innumerate rantings of a minority of credulous noisemakers waffling on about “freedom”.
Anybody pointing out that the game of making promises for people to hit 90% vaccinated is great motivator but will followed up with eh we may have been a bit naieve to think that would be a solution stuff that NPHET are now saying kinda undermines that whole strategy in practice – plus world has seen the reality that boosters are required since last June and only in November in Ireland are the masters now scrambling to get everyone to do that because ya know just being vaccinated isn’t enough yada yada
@Dave Hammond: yeah but boosters were only approved by the EMA in Oct so should Ireland have been ploughing boosters into people in June, difficult anyway given the 6 month gap required between second dose and booster. Also there is a difference in having 90% of the population vaccinated versus 90% of the eligible population vaccinated.
@Dave Hammond: By Nov 16th we administered 600,000 boosters and the booster rollout is on schedule. There is no scrambling.
The 21 day or 28 day gap between the first and second dose was a compromise between getting the vaccine out as fast as possible versus faster waning immunity, it was known that a shorter gap between doses would provide less durable immunity. Delta shortened the timeline further, with immunity dropping after only 4 months (against infection) and protection against hospitalisation and death diminishing after 6-7 months (Reference 1).
However, there is accumulating evidence that the booster, months after initial vaccination, may generate enhanced immunity quantitatively different from the original vaccination, that mimics the hybrid immunity (super immunity) seen in people vaccinated months after an initial infection (Reference 2).
People who have hybrid immunity have far stronger immunity against the Delta variant and other variants, and immunity appears to last far longer, possibly years, due to higher levels of memory B Cells. The effect appears to hinge on the long gap between the initial infection and vaccination, which provokes a strong durable immune response.
These Memory B cells are also generated at higher numbers if there’s at least several months spacing between vaccine doses (first and second, or two doses and booster). Canada spaced out their vaccination program to 16 weeks due to a vaccine shortage, this gap generated much stronger immunity, almost as robust as hybrid immunity:
“Extending the interval between vaccine doses could also mimic aspects of hybrid immunity. In 2021, amid scarce vaccine supplies and a surge in cases, officials in the Canadian province of Quebec recommended a 16-week interval between first and second doses (since reduced to 8 weeks).”
“A team co-led by Andrés Finzi, a virologist at the University of Montreal, Canada, found that people who received this regimen had SARS-CoV-2 antibody levels similar to those in people with hybrid immunity[10]. These antibodies could neutralize a swathe of SARS-CoV-2 variants — as well as the virus behind the 2002–04 SARS epidemic.
“We are able to bring naive people to almost the same level as previously infected and vaccinated, which is our gold standard,” says Finzi.
Also, new information from Israel (Referemce 4) indicates that immunity after the booster dose will likely last 9-10 months and possibly longer.
“By analyzing the antibody levels, researchers have concluded that the third shot could be effective for 9 – 10 months, or even longer, the researchers predicted.”
These observations of longer lasting antibodies agrees with in the previous observations of people with hybrid super immunity and those in Canada who had an extended gap between vaccine doses.
Refs.:
(1) Chemaitelly, H., Tang, P., Hasan, M.R., AlMukdad, S., Yassine, H.M., Benslimane, F.M., Al Khatib, H.A., Coyle, P., Ayoub, H.H., Al Kanaani, Z. and Al Kuwari, E., 2021. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. New England Journal of Medicine.
(2) Callaway, E., 2021. COVID super-immunity: one of the pandemic’s great puzzles. Nature, 598(7881), pp.393-394.
(3) Tauzin, A., Gong, S.Y., Beaudoin-Bussieres, G., Vezina, D., Gasser, R., Nault, L., Marchitto, L., Benlarbi, M., Chatterjee, D., Nayrac, M. and Laumaea, A., 2021. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a sixteen-week interval between doses). medRxiv.
(4) Pfizer booster shot could offer protection for 9-10 months — initial data
@GrumpyAulFella:@GrumpyAulFella: but we in Ireland started vaccinating last December – all the evidence emerged – firstly in Israel in the mid summer about waning vaccine and they quickly gave boosters – and it worked – the UK , the US and others followed- meanwhile we were busy congratulating ourselves that we had 0ver 90%vaccinated – we absolutely promised the public this was the way out – and in the past week NPHET have said maybe this was ‘ naive’ – so spare me the apologist nonsense – as for the approval process for boosters -it was implicit in my comment that we have been too slow on boosters including NIAC etc on approval process – we absolutely would not be where we are NOW and would have far far fewer people in. ICU at the moment if we administered boosters sooner – as a matter of fact they are saying 3 months after initial Jansen we should be boosting – so In my own case ideally I should have had have a booster last JUNE – not Nov / dec – people in Ireland are now showing up at centres looking for booster and they are being told to wait until they get their HSE text – so deflect all you like but the Pandemic Management here has been poor in some key aspects – very important aspects – including how sluggish they came to the table on the implementing the important boosters as part of the vaccine strategy – no need to rewrite what has happened. – the point stands – NZ are using the promise of 90% vax as ireland did but we in truth dropped the ball on our vaccine strategy as i said – some commentators here were slating those of us who pointed to israel in the summer and said we would absolutely be following suit – thats the fact of the matter actually
Four months into one of its worst Covid-19 outbreaks, Israel is seeing a sharp drop in new infections and severe illness, aided by its use of vaccine boosters, vaccine passports and mask mandates, scientists and health officials have said.
Israel was struck by its fourth coronavirus wave in June, fuelled by the fast-spreading Delta variant.
Rather than imposing new lockdown measures, the government bet on a third booster dose of the Pfizer vaccine for people age 12 and up, mandated face coverings and enforced use of a ‘Green Pass’ – proof of vaccination, recovery from the illness or a negative test for the virus – at restaurants and other venues, even for children.
Since peaking in early September, daily infections in Israel have fallen more than 80 per cent, with severe cases nearly halved.
“Day by day we are breaking the Delta wave,” prime minister Naftali Bennett said, crediting government policy for “close, smart and flexible management allowing life alongside coronavirus”.
Thanks to David and Dave for the intelligent updates. I initially thought that boosters were only needed for senior citizens & people with a struggling immune system; if they make such a difference in a population, it’s good to hear.
@Dave Hammond: yeah but I’m talking about the EU and you’re talking about the US, UK and Israel. Are any of these EU member states and do they take steers from the EMA? Israel started their booster campaign at the end of Aug. It wasn’t “soon after” they discovered waning vaccine cases in June, it was nearly 3 months after and at a time when they had over 80% of the eligible population vaccinated and they were not waiting for EMA approval either. You wanted yours in June?? We only had about 2m shots administered in June. Did you expect that Pfizer shots should be diverted at that point, without approval, to boosters and us with less that one third of vaccinations required for over 1/2s administered? That’s just nonsense.
Gonna be some shock when numbers go up & up in a few months like they did here despite us having lot more natural immunity from infections, 93% +12 vaccination rate & near 600,000 boosters administered
Someone should tell them & spare them the heartache
@David Lee: Austria going to be a disaster with their mandatory vaccination. Good lab experiment in a way. See how public health will evolve there. According to many, ICU will be still (and more) occupied to the tilt. We will see.
@David Lee: ye they seemed to have the tactics right but they didn’t capitalise on their success. They’ll likely see their first wave now and it could be a real doozy. Their demographics are very different too with a large Pacifica population who already have a lot of health issues and preexisting conditions with diabetes, a lot of smokers and poor health generally. It could spread like wildfire in those areas and cause serious damage.
Covid is with us long-term. Arderns policy was short term, shut down the entire country for a short while and then open everything up when it’s gone. This policy has proven to be incorrect, lockdowns only work short term
I have relatives there. I hope NZ is in a better position to beat Delta.
As of Monday Nov 22nd,
Ireland has 3,793,378 people who are fully vaccinated. That’s 76.13% of our population. Not bad going.
New Zealand has fully vaccinated 3,518,918 people against Covid. That’s only 68.69% of their population. Fingers crossed for them all that they keep up the testing and tracking.
Yet another housing forecast says the government will miss its completion targets
5 hrs ago
1.2k
24
The Morning Lead
RTB writes to major landlord Ires Reit over attempts to impose monthly common area charges
Eoghan Dalton
5 hrs ago
2.2k
13
RIP
'True legend': Tributes paid to former F1 boss Eddie Jordan after his death aged 76
Updated
12 hrs ago
44.8k
63
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 157 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 109 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 141 partners can use this purpose
Use limited data to select advertising 111 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 132 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 60 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 38 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 90 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 97 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 86 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 68 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say